News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
Policy
GlaxoSmithKline Says Roche’s Herceptin Infringes Patents
September 22, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WILMINGTON, Del., Sept 21 (Reuters) - Drugmaker GlaxoSmithKline sued Swiss rival Roche Holding AG (ROG.VX) on Tuesday for infringing a patent when it produces its cancer drug Herceptin, according to court documents filed on Monday.
Twitter
LinkedIn
Facebook
Email
Print
Legal
MORE ON THIS TOPIC
Government
Kennedy Postpones Preventive Care Panel Meeting After ‘Double-Edged Sword’ Supreme Court Win
July 10, 2025
·
2 min read
·
Tristan Manalac
Legal
Supreme Court Suspends Injunction Preventing RFK Jr.'s HHS Cuts
July 9, 2025
·
2 min read
·
Tristan Manalac
Tariffs
Trump Threatens 200% Pharma Tariffs—But Gives At Least 1-Year Grace Period
July 9, 2025
·
2 min read
·
Tristan Manalac
Alzheimer’s disease
Lilly Gets FDA Label Update for Alzheimer’s Drug To Mitigate Safety Concerns
July 9, 2025
·
2 min read
·
Annalee Armstrong
